| P50 | author | Eyal Schwartzberg | Q122973829 |
| | Abraham Weizman | Q27020194 |
| P2093 | author name string | Alexander M Ponizovsky | |
| | Eli Marom | |
| | Igor Barash | |
| | Michal Ben-Laish | |
| P2860 | cites work | Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study. | Q46026813 |
| | Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. | Q46814329 |
| | Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004. | Q47187309 |
| | Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis | Q47634507 |
| | Promises and pitfalls on the road to a mental health reform in Israel. | Q51824900 |
| | Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group | Q73437452 |
| | Antipsychotic drug use: McLean Hospital, 2002 | Q81853716 |
| | Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications | Q22241130 |
| | Oral paliperidone for schizophrenia | Q24242948 |
| | Increasing off-label use of antipsychotic medications in the United States, 1995-2008 | Q24628874 |
| | Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis | Q28293647 |
| | Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. | Q33960193 |
| | Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature | Q34330761 |
| | Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis | Q34349641 |
| | Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group | Q34719739 |
| | How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials | Q34733976 |
| | Optimal dosing of atypical antipsychotics in adults: a review of the current evidence | Q34803231 |
| | Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems | Q35608522 |
| | New users of antipsychotic medications among children enrolled in TennCare | Q35853703 |
| | Prevalence and correlates of "high dose" antipsychotic prescribing: findings from a hospital audit | Q36789676 |
| | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 |
| | Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies | Q37670925 |
| | Update on typical and atypical antipsychotic drugs | Q38047415 |
| | The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations | Q38089699 |
| | Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: a 10 years retrospective analysis | Q38440610 |
| | Trends in antipsychotic prescribing in schizophrenia in Auckland. | Q39756918 |
| | Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan | Q41064310 |
| | Patterns of antipsychotic medication use in Australia 2002-2007. | Q43122181 |
| | Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. | Q43145170 |
| | Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. | Q43873918 |
| | A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia | Q43975240 |
| P921 | main subject | Israel | Q801 |
| P304 | page(s) | 16 | |
| P577 | publication date | 2016-06-15 | |
| P1433 | published in | Israel journal of health policy research | Q27724393 |
| P1476 | title | Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013. | |
| P478 | volume | 5 | |